Praxis precision medicines to present at the american academy of neurology 2023 annual meeting

Boston, april 19, 2023 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will deliver presentations on its clinical stage programs at the upcoming american academy of neurology (aan) 2023 annual meeting, held april 22-27, 2023 in boston, massachusetts.
PRAX Ratings Summary
PRAX Quant Ranking